Stay updated on Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedNew sections and labels were added to the page’s help/navigation area, including No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study, and an updated Intervention/Treatment heading. The revision tag was updated to Revision: v3.6.0, replacing the previous Revision: v3.5.5.SummaryDifference0.2%

- Check15 days agoChange DetectedThe page's revision tag changed from v3.5.4 to v3.5.5, indicating a minor update to the page version.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a platform/template release. It does not modify any study details or data on the page.SummaryDifference0.0%

- Check57 days agoChange DetectedThe site’s displayed revision/version has been updated from v3.5.2 to v3.5.3, indicating a minor backend/UI release rather than a change to the study record.SummaryDifference0.0%

- Check65 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.0%

- Check79 days agoChange DetectedLocation entry updated from Padua, Italy 35128 to Padova, Italy 35128.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page.